7FRY

Structure of liver pyruvate kinase in complex with allosteric modulator 6

7FRY の概要

• エントリーDOI: 10.2210/pdb7fry/pdb
• Group deposition: Sulfonamide-containing catechols as modulators of liver pyruvate kinase (G_1002240)
• 分子名称: Pyruvate kinase PKLR, 1,6-di-O-phosphono-beta-D-fructofuranose, OXALATE ION, ... (7 entities in total)
• 機能のキーワード: pyruvate kinase, active site, inhibition, transferase
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 392077.32

構造登録者

Lulla, A.,Nilsson, O.,Brear, P.,Nain-Perez, A.,Grotli, M.,Hyvonen, M. (登録日: 2022-12-18, 公開日: 2023-04-12, 最終更新日: 2024-05-22)

主引用文献

Nain-Perez, A.,Nilsson, O.,Lulla, A.,Haversen, L.,Brear, P.,Liljenberg, S.,Hyvonen, M.,Boren, J.,Grotli, M.
Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators.
Eur.J.Med.Chem., 250:115177-115177, 2023

PubMed Abstract: The liver isoform of pyruvate kinase (PKL) has gained interest due to its potential capacity to regulate fatty acid synthesis involved in the progression of non-alcoholic fatty liver disease (NAFLD). Here we describe a novel series of PKL modulators that can either activate or inhibit the enzyme allosterically, from a cryptic site at the interface of two protomers in the tetrameric enzyme. Starting from urolithin D, we designed and synthesised 42 new compounds. The effect of these compounds on PKL enzymatic activity was assessed after incubation with cell lysates obtained from a liver cell line. Pronounced activation of PKL activity, up to 3.8-fold, was observed for several compounds at 10 μM, while other compounds were prominent PKL inhibitors reducing its activity to 81% at best. A structure-activity relationship identified linear-shaped sulfone-sulfonamides as activators and non-linear compounds as inhibitors. Crystal structures revealed the conformations of these modulators, which were used as a reference for designing new modulators.

PubMed: 36753880
DOI: 10.1016/j.ejmech.2023.115177

実験手法

X-RAY DIFFRACTION (1.958 Å)